AI news
AI model reviews
AI tools
How-to guides
Our staffAboutContact

Abridge AI review 2026: the ambient scribe's features, pricing and limits

Abridge AI is the ambient scribe many big Epic health systems pick. We weigh its features, hidden pricing, published results and the weak spots clinicians report.

Abridge image from its official website

Our verdict on Abridge

4.0/ 5
4.0
Features
9
Ease of use
8
Value
6.5
Performance
8

Abridge is probably the safest third-party ambient scribe for large Epic-based health systems, with strong traceability and the deepest evidence base. Solo clinicians and small practices should skip it, since there's no public way to buy it, and every buyer should negotiate consent, retention and exit terms carefully.

Pricing No published pricing; enterprise contracts via sales (Vero estimates about $2,500 to $7,200+ per clinician per year); no public free plan or trial

Visit Abridge

Here's the short version. Abridge AI is an ambient AI scribe for hospitals and large health systems: it listens to the conversation between a clinician and a patient, drafts the clinical note in real time and drops it into the electronic health record (mostly Epic) for the clinician to check and sign. It's probably the most credentialed product in its category, but you can't simply buy it as a solo doctor, and the measured time savings are smaller than the marketing implies.

Nobody at The AI Future has used Abridge with real patients, and I'm not going to pretend otherwise. For this review we compared Abridge using its own product pages and release notes, published studies, health-system reports, independent analyses and clinician comments on Reddit, as of early November 2026. Where someone else measured something, I'll say who.

My one-line take: if your employer already runs Abridge inside Epic, it's likely worth learning properly, because the clinicians who use it on most visits get most of the benefit.

Abridge AI in brief

Abridge was founded in 2018 by cardiologist Shiv Rao, and the company came out of the Pittsburgh Health Data Alliance, a collaboration between the University of Pittsburgh, UPMC and Carnegie Mellon, according to Contrary Research. It's an enterprise company. Its customer page lists 300+ health systems, including Mayo Clinic (2,000+ physicians), Johns Hopkins, Memorial Sloan Kettering and WashU Medicine with BJC Health (4,000+ clinicians).

The money behind it is serious. A competitor's Abridge review on the Vero blog puts total funding at about $812 million by early 2026, most recently a $300 million Series E led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation. (Vero sells a rival scribe, so I've used its review for facts it sources and treated its opinions with care.)

On the Abridge homepage the company claims it powers "100M+ Conversations" a year. It also won Best in KLAS for ambient AI; the KLAS award page covers the 2025 win, and the site's menu now calls Abridge the "2025 and 2026 market leader".

A simple mental model helps here. Abridge is a pipeline with four stages: capture audio on a phone in the exam room, transcribe and separate the speakers, generate a structured note, then link every sentence of that note back to the part of the conversation it came from. The last step is the one I'd pay attention to, because it's what lets a busy clinician verify a draft in seconds instead of re-listening to the visit.

Key features

Ambient notes inside Epic

The core product records the visit in Epic's Haiku mobile app and puts the draft note in Hyperspace, the desktop Epic client, with "Linked Evidence" so you can trace each line to the transcript. You'll find that workflow described on the product page, which also says it works across outpatient, emergency and inpatient care.

Breadth is decent. Vero lists support for 28+ languages and 55+ specialties, and notes integrations with athenahealth, eClinicalWorks and Oracle Cerner that are less embedded than Epic's.

Orders, visit topics and inpatient notes

The October 2026 release added a lot. Going by the October release notes, In-Visit Orders now stages orders in Epic as they're discussed, updating them if the plan changes mid-conversation.

Visit Topics shows primary care clinicians which chronic conditions to address, and for Medicare Advantage patients it flags conditions documented last year but not yet this year. Inpatient H&Ps and progress notes now pull in chart data such as new labs and vitals, with each chart-driven item cited to its source.

Abridge Assistant

This is the newer chat layer. The Assistant page describes it answering clinical questions with cited sources, summarising what's changed for each patient on the day's schedule, pre-filling calculators like MELD and CHA2DS2-VASc, and drafting referral letters and handoffs. Clinicians can also earn AMA PRA Category 1 Credit for eligible questions, which I think is a clever hook (doctors need those credits anyway, for what it's worth).

Revenue cycle features

Abridge also sells coding accuracy to finance teams, and that's a separate pitch from saving doctors time. Contrary Research says the company began checking and validating billing codes in real time in 2025, and Vero lists ICD-10 and HCC coding plus real-time prior authorisation through an Availity partnership announced in January 2026. That's where much of the business case seems to sit.

Hallucination guardrails

Abridge publishes more about its error handling than most rivals. Its paper "The Science of Confabulation Elimination" describes guardrails, backed by over a thousand hours of human validation, that revise first drafts before a clinician sees them. Vero's summary of the paper says the system catches 97% of hallucinations against 82% for GPT-4o used directly. That's a vendor's own benchmark, so I'd treat it as a claim worth checking in your own pilot, not a settled number.

Abridge AI pricing and plans

There's no public price. Abridge doesn't have a pricing page, and its contact form is the route in. The newest privacy policy (updated August 27, 2026) mentions collecting card details "via Self-Serve", which hints at some direct sign-up path, but I couldn't find a public plan or price for one. That's frustrating for a buyer.

BuyerPriceHow you get it
Individual clinicianNot publishedNo public self-serve plan found
Small practiceNot publishedContact sales
Health systemEstimated $2,500 to $7,200+ per clinician per year (Vero estimate)Negotiated enterprise contract
Free plan or trialNone listedNot available publicly

Checked November 2026. The estimate in the table comes from Vero, which calls it a market estimate; The D(AI)LY Brief at beri.net, checking on September 26, 2026, lists Abridge simply as "Contact sales" and declined to guess. I'd use the range as a rough budgeting anchor only.

A worked example on cost per minute saved

Let's run the numbers, because this is how a CFO will look at it. The beri.net analysis cites a five-centre study in which ambient scribes saved about 16 minutes of documentation per eight hours of patient care. Take a clinician with four clinic days a week and about 46 working weeks a year: that's roughly 184 clinic days, or about 49 hours saved a year. At the top of Vero's range ($7,200), you'd be paying around $147 per hour saved; at $2,500 it's closer to $51. My arithmetic, not anyone's published figure. For a physician whose time is billed at several hundred dollars an hour, that's probably fine, and the burnout benefit sits on top.

The catch is adoption. The same study found only 32% of users used a scribe in more than half their visits, and those heavy users got two to three times the savings. If you license every clinician and a third use it properly, your real cost per hour saved can easily double.

Performance and independent testing

Abridge has more published outcome data than most competitors, though a lot of it comes from customers' own pilots, so read the numbers with that in mind.

  • At the University of Chicago, Abridge users cut note-writing time by 1.8 minutes per appointment (15.9%) versus matched controls, with no significant change in after-hours documentation, as beri.net reports.
  • Abridge's UChicago press release says 90% of clinicians gave patients undivided attention after 30 days, up from 49% before the pilot.
  • UC Davis Health reported a 52.7% drop in cognitive load and an average 1.6 hours a week saved on notes among pilot clinicians.
  • Kaiser Permanente's quality review rated scribe notes 4.35 out of 5 on a modified PDQI scale, with thoroughness scoring lowest and multi-speaker tracking a named weakness, according to beri.net.

Those are decent results. They're also modest. Sixteen minutes a day is real time, but it isn't the hour-a-day story you'll hear in a sales demo, and the best randomised evidence for the category (a NEJM AI trial covering DAX Copilot and Nabla, not Abridge) found usage in only about a third of visits.

Weak spots and failure modes

Clinician comments on Reddit split sharply by setting. One user in a thread about poor Abridge output wrote that "The HPI reads like it was written by a college student who learned from watching five seasons of Gray's Anatomy." In the same thread an inpatient doctor called the generated assessment and plan useless for patients with "three failing organ systems", while another user, who'd used Abridge for over a year, said they found it "much better than Dax copilot" once they set up templates and picked their specialty in settings.

The pattern I see is fairly consistent: primary care, psychiatry and outpatient work seem to go well, while complex inpatient cases expose the model. Omissions are the scarier failure. An OHSU study of five anonymised scribe platforms, cited by beri.net, found that about 76% of errors were things said in the room that never made it into the note, and a reviewer can't see what's missing.

Then there's consent. A proposed class action filed in December 2025 alleges that Sharp HealthCare recorded patients with Abridge without consent and that notes falsely said patients "consented", KPBS reported. The suit estimates more than 100,000 patients may have been recorded. These are allegations, not findings, and both Sharp and the plaintiff's lawyers declined to comment on pending litigation. Still, I think it's the clearest warning in this review: the consent workflow is yours to get right, not the vendor's. Our piece on the dangers of AI covers the wider privacy picture, and our AI regulation explainer covers the rules that are starting to apply.

Best suited to

Abridge fits large US health systems on Epic that want an embedded workflow, published evidence and enterprise governance. It also suits systems where coding accuracy and prior authorisation matter as much as note quality.

It's a poor fit if you're a solo clinician, a small practice that wants to start this week, or a clinic outside the US: Vero says Abridge runs on US data centres and that Canadian PIPEDA compliance isn't confirmed. If you're in that group, our guide to the best AI SOAP note tools lists products you can actually sign up for.

Your situationAbridge?
Epic health system, 500+ cliniciansStrong shortlist candidate
Oracle Health or athenahealth systemPossible, but check integration depth
Small group practiceProbably not available
Solo clinician who wants a trial todayNo

Abridge alternatives worth considering

  • Epic AI Charting is Epic's own scribe, rolled out on February 4, 2026, per beri.net. It's native and drafts notes and suggests orders, but Epic hasn't published pricing or outcome data for it yet.
  • Microsoft Dragon Copilot combines dictation and ambient capture. Beri.net reports that Mount Sinai picked it over Abridge after a bake-off on business terms, though the published randomised trial of its ambient engine showed no significant time effect.
  • Freed is the pick for small practices: beri.net lists Starter at $39 per clinician per month (40 notes), Core at $79 and Premier at $119, with self-serve sign-up.

Also worth a look is our Suki AI review, and the wider list of AI healthcare startups if you're scanning the market.

Verdict

I'd give Abridge 4 out of 5. For an Epic-based health system it's probably the safest third-party bet right now: the Linked Evidence design makes drafts quicker to verify, the October 2026 release pushes it well past note-taking, and the evidence base is deeper than its rivals'. What holds it back is hidden pricing, no public route in for small practices, and a time saving that's real but modest. Honestly, the biggest decision isn't Abridge versus a rival. It's whether Epic's native tool will be good enough by the time your contract renews, so I'd negotiate exit terms before signing anything long.

FAQ

What is Abridge AI?

Abridge AI is an ambient clinical documentation platform. It records the clinician-patient conversation with consent, writes a structured draft note during the visit and links each part to the transcript so the clinician can verify it. It's sold to health systems and is deeply integrated with Epic, with other EHR integrations available.

How much does Abridge AI cost?

Abridge doesn't publish prices, and you'll need to contact sales. Vero, a competing scribe company, estimates enterprise contracts at about $2,500 to $7,200+ per clinician per year. There's no public free plan or trial, and I couldn't find a published self-serve price as of November 2026.

Is the Abridge AI scribe accurate?

It's good but not perfect. Kaiser Permanente rated notes 4.35 out of 5 on a quality scale, and Abridge says its guardrails catch most hallucinations before review. Clinicians on Reddit report weaker results for complex inpatient cases, and omissions are the main risk, so every draft still needs a careful read before you sign it. I'd also audit a sample of unedited notes against the audio.

Can an individual doctor use Abridge?

Usually only through an employer. Abridge sells enterprise contracts to health systems, and most clinicians get access when their hospital rolls it out; UC Davis Health, for example, opened it to all ambulatory attendings, with a 15-minute online training to get started. If you're independent, a self-serve scribe like Freed is the realistic option.

Does Abridge work with Epic?

Yes, and it's the main strength. Abridge records in Epic's Haiku app, puts the draft in Hyperspace and now stages orders in Epic. Oracle Cerner, athenahealth and eClinicalWorks integrations exist but are less embedded.

What users are saying

We read about 60 clinician comments across four Reddit threads on AI scribes from March to June 2026, but only 7 discussed Abridge directly, so this is a small sample. Outpatient, psychiatry and resident users were positive about time saved, while one thread was dominated by complaints about inaccurate HPIs and weak inpatient assessments and plans.

Common praise

  • Saves a lot of note-writing time in outpatient clinics
  • Specialty templates, such as a psych template, improve output
  • AI chat and templates let users reshape notes

Common complaints

  • Inaccurate or generic HPI text
  • Assessment and plan too shallow for complex inpatient patients
  • Editing time can eat into the time saved

Based on: Reddit thread on Abridge output quality, Reddit thread on AI scribes and editing time, r/Residency thread on ambient scribes in residency, Reddit thread on AI-written notes and discharge summaries

What we like

  • Deep Epic integration: records in Haiku, drafts in Hyperspace, stages orders in Epic
  • Linked Evidence ties each note line to the transcript for quick checking
  • More published outcome data than most rivals (UChicago, UC Davis, Kaiser Permanente)
  • October 2026 release adds In-Visit Orders, Visit Topics and chart-informed inpatient notes
  • Abridge Assistant adds cited clinical answers, calculators and letter drafts

What could be better

  • No public pricing and no public route in for solo clinicians or small practices
  • Measured time savings are modest, about 16 minutes per clinical day in the largest multi-site study
  • Some clinicians report weak output for complex inpatient cases
  • Consent workflow risk, highlighted by the pending Sharp HealthCare lawsuit

Keep reading